Welcome to our dedicated page for Agilon Health news (Ticker: AGL), a resource for investors and traders seeking the latest updates and insights on Agilon Health stock.
agilon health, inc. provides a healthcare services platform that partners with primary care physician groups and health systems to transition senior patient care to a value-based Total Care Model. Company updates commonly cover Medicare Advantage members and ACO model beneficiaries on the agilon platform, payor contract economics, market exits, clinical programs, data and technology investments, and operating discipline within a Medicare-centric capitated care model.
News also includes quarterly and annual financial results, revenue, medical margin and Adjusted EBITDA guidance, conference participation, and governance changes such as CEO appointments and board membership. Recurring disclosures tie membership trends, payor alignment and clinical execution to the economics of agilon’s physician partnerships.
Agilon Health, Inc. (NYSE: AGL) reported a strong first quarter for 2021, achieving total revenues of $413 million, a 42% increase compared to the previous year. Membership numbers grew by 35%, reaching approximately 165,300, with further increases expected due to a new group Medicare Advantage contract. Although they reported a net loss of $14 million, adjusted EBITDA improved to $4 million, up from $3 million in 2020. The company plans to support growth with IPO proceeds, aiming for 175,000 to 177,000 members by Q2 2021.
agilon health, inc. (NYSE: AGL) will release its financial results for Q1 2021 after market close on May 26, 2021. A conference call will occur on May 27, 2021, at 8:30 AM ET, to discuss the results. Participants can join by dialing (855) 435-0829 for the U.S. or +1 (639) 491-2399 internationally, using the code 9436419. The call will be available for on-demand listening shortly after. agilon health focuses on empowering primary-care physicians for better patient care, especially for seniors, aiming to transform healthcare delivery.
agilon health, inc. (NYSE: AGL) successfully closed its initial public offering of 53,590,000 shares at $23.00 each, generating approximately $1,233 million in gross proceeds. This includes the full exercise of underwriters’ option for an additional 6,990,000 shares. Trading commenced on the New York Stock Exchange on April 15, 2021. The offering was led by J.P. Morgan, Goldman Sachs & Co. LLC, and BofA Securities. agilon health empowers primary care physicians to enhance value-based healthcare delivery, focusing on senior patients.
agilon health has priced its initial public offering (IPO) at $23.00 per share, offering 46,600,000 shares for a total gross proceeds of approximately $1,072 million. The shares will start trading on the New York Stock Exchange under the ticker symbol AGL on April 15, 2021, with the expected closing date on April 19, 2021. The underwriters have a 30-day option to purchase an additional 6,990,000 shares. The offering is managed by J.P. Morgan, Goldman Sachs, and BofA Securities, among others.